Target intelligence / Profile preview

CAV2 divergent transcript (CAV2-DT)

Target
CAV2-DT
Molecular classification
Other (Long non-coding RNA), Non-protein-coding RNA
01

Overview

CAV2 divergent transcript (CAV2-DT, also known as AC002066.1) is a long non-coding RNA gene located on chromosome 7, close to the CAV2 locus[3]. As a lncRNA, it does not encode a protein and is not considered a classic drug target (such as a receptor or enzyme). There are currently no data available about its biological function, disease association, drug interactions, or roles as a biomarker in clinical settings[3]. Its main molecular classification is as a non-protein-coding RNA. No notable issues with the target name or entry were identified. If more information emerges in the scientific literature, especially about its function or disease relevance, this status may change in the future.

Other names
AC002066.1CAV2-DT
02

Mechanism of action

None known

03

Biological functions

Unknownpotentially gene regulation (typical for lncRNAs)
04

Disease associations

None established; no disease association reported in major databases as of current knowledge

Beyond the preview

Go deeper on CAV2 divergent transcript (CAV2-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CAV2 divergent transcript (CAV2-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call